The focus of regulation shifts from content competition to preventing consumer misunderstanding

Food authorities, on the one hand, are abolishing the upper standard for daily probiotic intake to expand autonomy in product design, while on the other hand they are tightening safety management by restricting the mixing of ingredients that carry intake warnings related to liver disease. This is interpreted as an effort to reduce risks arising from combined consumption and inflated expectations without hindering industry innovation.

In the same context, products that meet low-sugar standards through the use of sweeteners will be restricted from using labels that suggest blood sugar management effects. This carries significant meaning as an attempt to correct the problem of consumers’ judgment being clouded when different messages about low sugar, functionality, and health management are mixed together in a single product.

The axis of probiotic competition is being reorganized around strains and production technology

Probiotics have already established themselves as a major market worth about 370.9 billion won, and the easing of upper-limit regulations is likely to further intensify competition beyond simply increasing dosage and toward differentiation by strain. As merely raising the content becomes less persuasive, the key standard is becoming which strains are used and whether their characteristics can be maintained all the way through production and consumption.

This trend is leading companies, support institutions, and academia alike to move to secure functional evidence and proprietary ingredients. The acquisition of individually approved ingredients such as perilla extract and the launch of the Health Functional Food Research Society show that future market competitiveness will be determined less by advertising copy and more by scientific verification and the accumulation of data.

In sales channels, broader experience; in consumer protection, stronger demands for verification

In the distribution field, methods of presenting health management not as a product purchase but as a lifestyle experience are spreading. Spaces like Olive Better Seongsu, which put sampling, comparison, and curation front and center, reflect growing consumer demand to directly check ingredients and how products should be used.

However, as sales channels diversify, concern over exaggerated claims and sales targeting vulnerable groups is also growing. Sanctions against Lotte Home Shopping, a survey showing that 53.2% of users experienced complaints or harm related to purchases, and inspections focused on facilities used by older adults such as senior centers and welfare centers reveal that market expansion does not automatically lead to greater trust.

Corporate strategy also shifts from single-product sales to integrated solutions and overseas expansion

Companies are offering bundled solutions rather than single products in response to regulatory changes and shifting consumer expectations. The Epiday-centered strategy, which links obesity treatment drugs, apps, and personalized supplement products, is a model that takes responsibility for lifestyle management even after medication, showing that functional products are expanding into the space between healthcare and digital management.

At the same time, manufacturers are shifting their center of gravity toward rapidly growing overseas markets rather than a domestic market where growth has slowed. Ultimately, the health functional food industry is changing into a structure in which companies that can not only design and manufacture products in line with each country’s regulations but also explain them in ways that prevent consumer misunderstanding will have the advantage.